Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_assertion type Assertion NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_head.
- NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_assertion description "[Characteristic features of SLE include (1) polyclonal B cell activation, (2) overexpression of the immune stimulatory cytokine interleukin-6 (IL-6), (3) defective tolerance to self antigens, and (4) production of anti-DNA antibodies (Ab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_provenance.
- NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_assertion evidence source_evidence_literature NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_provenance.
- NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_assertion SIO_000772 8576314 NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_provenance.
- NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_assertion wasDerivedFrom befree-20140225 NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_provenance.
- NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_assertion wasGeneratedBy ECO_0000203 NP262971.RAKvRhZ1JaqtudjEiw9YQQPfn-ZwKzp2DkfdUMFoLkwM0130_provenance.